Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1'-Acetoxychavicol acetate is a phenol ester with a wide range of biological activities including antioxidative, anti-obesity, antibacterial, anti-parasitic, chemopreventive, and anticancer properties. It inhibits xanthine oxidase and activates TRPA1, an ion channel involved in pain signaling. It has been shown to inhibit adipogenesis, decrease visceral fat in animal models, and exhibit antitumor activities in various cancer models. Additionally, it acts as a NF-kappaB inhibitor and suppresses nitric oxide synthase production. It is naturally found in plants of the Zingiberaceae family, notably Alpinia galanga.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1'-acetoxychavicol acetate.